AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

COCHLEAR LTD

133.850

-2.250-1.65%

Volume:175.68K

Turnover:23.55M

Market Cap:8.75B

PE:59.54

High:135.670

Open:135.260

Low:132.330

Close:136.100

52wk High:297.775

52wk Low:88.740

Shares:65.40M

Float Shares:65.14M

Volume Ratio:0.83

T/O Rate:0.27%

Dividend:4.30

Dividend Rate:3.21%

EPS(TTM):2.248

EPS(LYR):2.248

ROE:7.98%

ROA:9.71%

PB:5.03

PE(LYR):59.54

Loading ...

Overview Company News Filings

Jarden Analysts See Some Hope for Cochlear -- Market Talk

Cochlear Has Limited Scope for Sales Recovery -- Market Talk

Cochlear's Outlook Is Unclear Despite Margin Support -- Market Talk

BUZZ-Citi reduces PT for Australia's Cochlear post weak trading update

3 ASX Stocks Estimated To Be Undervalued By Up To 48.5%

Simply Wall St.

Asia Morning Call-Global Markets

BUZZ-Sonova leads European hearing-care stocks lower after Cochlear warning

Cochlear Bull Thinks Volumes Can Recover With Time -- Market Talk

Cochlear's Guidance Cut 'Far Worse Than Anticipated,' Multiple Also at Risk, Jarden Says

MT Newswires Live

Cochlear Shares Plunge as U.S. Sentiment Weakens Profit Outlook

BUZZ-Australia's Cochlear slips; Jarden flags weak demand on Middle East conflict disruptions

ASX Midday Sector Update: Consumer Staples Stocks Rise, Cochlear Weighs on Health Care

MT Newswires Live

BRIEF-Cochlear Reduces Underlying Net Profit Guidance For Fy26 To A$290-330 Million

BUZZ-Australia's Cochlear tanks on potential order cancellations, revised annual outlook

Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact

Cochlear Says Trading Conditions for Implants Weaker Than Expected Since January; Shares Hit 10-Year Low

MT Newswires Live

Cochlear cuts fiscal 2026 earnings outlook on Middle East‑led demand uncertainty

Shares of Cochlear Falls 38.6% to a$103.07, Lowest Level Since April 14, 2016

THOMSON REUTERS

Stock Track | Cochlear Ltd Plummets 33.74% Intraday on Earnings Guidance Cut and Middle East Sales Uncertainty

Cochlear Ltd - Sees Second Half Sales Growth of 2-6% in Constant Currency

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/COH.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","market":"AU","secType":"STK","nameCN":"COCHLEAR LTD","latestPrice":133.85,"timestamp":1788144850351,"preClose":136.1,"halted":0,"volume":175684,"delay":0,"changeRate":-0.016531961792799414,"nameEN":"COCHLEAR LTD","floatShares":65138365,"shares":65398462,"eps":2.248,"marketStatus":"Trading","change":-2.25,"latestTime":"08-31 12:54:10 AEST","open":135.26,"high":135.67,"low":132.33,"amount":23546800,"amplitude":0.024541,"askPrice":133.85,"askSize":2,"bidPrice":133.83,"bidSize":31,"shortable":3,"etf":0,"ttmEps":2.248,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788156000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":136.1,"dividendRate":0.032131,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":0.828865,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"COH.AU","preClose":136.1,"auctionPrice":135.26,"auctionVolume":13845,"auctionTime":1788134348442,"referenceTime":1787913003093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788134348442}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"COH.AU\",,,,,undefined,":{"symbol":"COH.AU","floatShares":65138365,"roa":"9.71%","roe":"7.98%","lyrEps":2.248,"volumeRatio":0.828865,"shares":65398462,"dividePrice":4.3008,"high":135.67,"amplitude":0.024541,"preClose":136.1,"low":132.33,"week52Low":88.74,"pbRate":"5.03","psRate":"3.73","week52High":297.775,"institutionHeld":0,"latestPrice":133.85,"committee":0.878788,"eps":2.248,"divideRate":0.032131,"volume":175684,"delay":0,"ttmEps":2.248,"open":135.26,"prevYearClose":257.41,"prevWeekClose":136.1,"prevMonthClose":119.94,"prevQuarterClose":121.75,"fiveDayClose":135.77,"twentyDayClose":120.74,"sixtyDayClose":100.45,"dividendPayoutRate":1.9096682506550604,"dividendGrowthYears":5,"dividendGrowthRate":0.0117647058823529,"fiveYearAvgDividendRate":0.018048554743331537},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COH.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"COH.AU","amount":1.3,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-22","defaultRemindTime":1789948800000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-22","currency":"AUD","dateTimestamp":1789912800000,"payDate":"2026-10-14"},{"date":"2026-08-18","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-19","symbol":"COH.AU","amount":2.15,"announcedDate":"2026-02-12","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-20","name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-13","payableDate":"2026-03-20","currency":"AUD","dateTimestamp":1773838800000,"payDate":"2026-04-13"},{"date":"2026-02-13","symbol":"COH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770937200000,"name":null,"time":"","dateTimestamp":1770901200000,"actualEps":null},{"date":"2025-09-18","symbol":"COH.AU","amount":2.15,"announcedDate":"2025-08-15","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-19","defaultRemindTime":1758153600000,"name":"COCHLEAR LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-13","payableDate":"2025-09-19","currency":"AUD","dateTimestamp":1758117600000,"payDate":"2025-10-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COH.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-03-25","recordDate":"2021-03-26","paymentDate":"2021-04-20","value":1.15,"currency":"AUD"},{"executeDate":"2021-09-23","recordDate":"2021-09-24","paymentDate":"2021-10-18","value":1.4,"currency":"AUD"},{"executeDate":"2022-03-28","recordDate":"2022-03-29","paymentDate":"2022-04-21","value":1.55,"currency":"AUD"},{"executeDate":"2022-09-21","recordDate":"2022-09-23","paymentDate":"2022-10-17","value":0.87,"currency":"AUD"},{"executeDate":"2023-03-21","recordDate":"2023-03-22","paymentDate":"2023-04-14","value":1.0075,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COH.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629355070","title":"Jarden Analysts See Some Hope for Cochlear -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2629355070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629355070?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:34","pubTimestamp":1776908040,"startTime":"0","endTime":"0","summary":"0134 GMT - Cochlear won't get a good start to its next fiscal year but there is still some cause for optimism, Jarden analysts say. While the hearing implant maker has slashed its FY 2026 profit guidance on weak unit sales, the Jarden analysts tell clients in a note that the Australian company's services segment appears to be rebounding into fiscal 2027. Elsewhere, they acknowledge that competition is making acoustics revenue growth unpredictable, but still cite 11% March-quarter growth as a positive. Jarden cuts its target price on the stock 25% to A$169.00 and maintains a neutral rating. Shares are down 1.4% at A$98.19. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOPE","BK7007","COH.AU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629778620","title":"Cochlear Has Limited Scope for Sales Recovery -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2629778620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629778620?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:04","pubTimestamp":1776906240,"startTime":"0","endTime":"0","summary":"0104 GMT - Cochlear loses its buy rating at UBS, where analysts see limited scope for the hearing-implant maker to lift annual sales growth back to 10% any time soon. Cutting their recommendation to neutral, the investment bank's analysts tell clients that a drop in U.S. unit sales at a time when Cochlear is releasing a new implant into a vast underpenetrated adult market is a clear negative. They say that overburdened European health systems and reimbursement cuts in China add to the pressure on sales. The analysts warn that the challenges facing the Australian company are entrenched, with earnings visibility at a post-Covid low. UBS slashes its target price 64% to A$109.00. Shares are down 2.2% at A$97.40. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629307269","title":"Cochlear's Outlook Is Unclear Despite Margin Support -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2629307269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629307269?lang=en_us&edition=fundamental","pubTime":"2026-04-23 08:39","pubTimestamp":1776904740,"startTime":"0","endTime":"0","summary":"0039 GMT - Cochlear's decision to cut manufacturing and accelerate restructuring should help support margins, but the outlook remains unclear, according to Macquarie analysts. They are positive on the hearing-implant maker's decision to shrink manufacturing output by more than the fall in sales, telling clients in a note that this will reduce inventory. However, they warn that hearing care has been deprioritized by U.S. consumers and European healthcare systems, and see the risk that weak consumer sentiment could also weigh on processor upgrade volumes. Macquarie cuts its target price 52% to A$115.00 and stays neutral on the stock, which is down 1.1% at A$98.51. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629807332","title":"BUZZ-Citi reduces PT for Australia's Cochlear post weak trading update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629807332","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629807332?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:48","pubTimestamp":1776890890,"startTime":"0","endTime":"0","summary":"BUZZ-Citi reduces PT for Australia's Cochlear post weak trading update** Analysts at Citi said Cochlear's COH.AX trading update on Wednesday highlighted a \"laundry list of headwinds far beyond what we think most anticipated\"** Shares of the hearing implants maker crashed over 40% on Wednesday after a weak trading update** Brokerage reduces price target for stock to A$95/shr; downgrades rating to \"sell\"** Citi sees lower-than-expected demand for implants from co in developed markets amid persistent reductions in discretionary spending; brokerage cut its forecast for implant growth rate from high to mid-single digits** Brokerage lowers FY26 NPAT estimates for firm by 22%** COH down 61.8% YTD, as of last close","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N4152GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629075751","title":"3 ASX Stocks Estimated To Be Undervalued By Up To 48.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629075751","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629075751?lang=en_us&edition=fundamental","pubTime":"2026-04-23 03:04","pubTimestamp":1776884683,"startTime":"0","endTime":"0","summary":"In the last week, the Australian market has stayed flat, yet it is up 14% over the past year with earnings forecasted to grow by 12% annually. In this context of steady growth and positive earnings outlook, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on market inefficiencies.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/3-asx-stocks-estimated-to-be-undervalued-by-up-to-485","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-coh/cochlear-shares/news/3-asx-stocks-estimated-to-be-undervalued-by-up-to-485","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JDO.AU","BK7062","BK7107","WRK.AU","BK7007","BK7084","BK7094","CGS.AU","SDR.AU","TPW.AU","NXL.AU","BK7135","LGI.AU","MFG.AU","COH.AU","ELS.AU","BK7043","RDY.AU","GMD.AU","BK7049","BK7016","BK7104","BK7060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629024367","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2629024367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629024367?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:30","pubTimestamp":1776882635,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsApril 23 (Reuters) -  Stock Markets  closing level)Net ChngStock MarketsNet ChngS&P/ASX 200**8843.6-105.8NZX 50**12945.613.27DJIA49360.05210.67NIKKEI**59585.86236.69Nas","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N41524Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7007","BHP.AU","COH.AU","BK7507","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629133380","title":"BUZZ-Sonova leads European hearing-care stocks lower after Cochlear warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2629133380","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629133380?lang=en_us&edition=fundamental","pubTime":"2026-04-22 16:02","pubTimestamp":1776844978,"startTime":"0","endTime":"0","summary":"BUZZ-Sonova leads European hearing-care stocks lower after Cochlear warning** Shares in Sonova SOON.S fall over 4%, leading a drop in sector peers after Australian hearing-implant maker Cochlear COH.AX cut its FY forecast, citing uncertainty and weaker demand tied to the Middle East war** \"While the generally more challenging market environment may also affect Sonova, the impact should be limited given the relatively small contribution of cochlear implants to Sonova's overall business,\" says Vontobel analyst Sibylle Bischofberger** Cochlear implants account for around 8% of the Swiss hearing aid maker's group sales, the analyst says** Elsewhere in the hearing-care sector, Amplifon AMPF.MI and Demant DEMANT.CO down over 2%, GN Store Nord GN.CO down 1.6%, following a 41% slide in Cochlear shares** Softening cochlear demand in developed markets, reimbursement pressure in China, and Middle East-led disruption point to a weaker, more prolonged downcycle, Jefferies says** Including Wednesday","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL8N4150HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629092926","title":"Cochlear Bull Thinks Volumes Can Recover With Time -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2629092926","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629092926?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:33","pubTimestamp":1776839580,"startTime":"0","endTime":"0","summary":"0633 GMT - Cochlear's bull at Jefferies slashes their target price on the hearing-implant maker's guidance downgrade while thinking market volumes can recover over the longer term. Analyst David Stanton tells clients in a note that the investment bank's channel checks suggest that health insurers in developed and developing markets are under pressure, which leads to delays in demand for implants. Stanton points out that insurers in developed markets are increasing deductibles, while many patients see implantation as a semi-elective procedure that can be delayed. Jefferies cuts its target price 52% to A$137.00 and keeps a buy rating on the stock, which closed 41% lower at A$99.58. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629133091","title":"Cochlear's Guidance Cut 'Far Worse Than Anticipated,' Multiple Also at Risk, Jarden Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2629133091","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629133091?lang=en_us&edition=fundamental","pubTime":"2026-04-22 13:39","pubTimestamp":1776836361,"startTime":"0","endTime":"0","summary":"Cochlear's (ASX:COH) cut to fiscal 2026 profit guidance \"is far worse than anticipated,\" and the company's multiple is also at risk given its recent inability to provide reliable forecasts, Jarden sai","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629096328","title":"Cochlear Shares Plunge as U.S. Sentiment Weakens Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2629096328","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629096328?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:03","pubTimestamp":1776830580,"startTime":"0","endTime":"0","summary":"SYDNEY--Cochlear shares are on course for their worst day since the hearing-implant maker went public in 1995, tumbling 40% after the Australian company slashed its annual profit guidance on weak U.S. consumer sentiment and the Iran conflict.Cochlear, which developed the world's first hearing implant in the 1970s after its founder experimented with a blade of grass inside a shell found on an Australian beach, warned that its annual profit would be as much as 33% lower than previously flagged.It pointed to softer recent demand in developed markets and uncertainty over Middle East sales for the remainder of its fiscal year, which ends June 30.\"Consumer sentiment has declined in key markets, reaching historic lows in the U.S.,\" Cochlear said Wednesday. \"The decline appears to be affecting discretionary healthcare decisions in the adults and seniors segment, adding to demand uncertainty in the near term.\". Midway through Wednesday's trading session, Cochlear's Australia-listed stock was do","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Cochlear Shares Plunge as U.S. Sentiment Weakens Profit Outlook","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629952340","title":"BUZZ-Australia's Cochlear slips; Jarden flags weak demand on Middle East conflict disruptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2629952340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629952340?lang=en_us&edition=fundamental","pubTime":"2026-04-22 11:49","pubTimestamp":1776829776,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear slips; Jarden flags weak demand on Middle East conflict disruptionsUpdates** Shares of Cochlear COH.AX fall as much as 41.7% to A$97.88, their weakest intraday trading session ** Stock touches its lowest level since February 11, 2016. ** Jarden says the hearing implants maker largely affected by implant segment, Middle East disruptions among others. ** Says weak product mix, competition have dragged demand. ** Company expects FY26 underlying net profit to be between A$290 million and A$330 million , sharply lower from its previous forecast of A$435 million to A$460 million** \"This guidance downgrade is far worse than anticipated\" - Jarden** Company warns of risks arising from Middle East conflict, including potential order cancellations** Expects nearly additional A$25 million aftertax hit to second-half earnings** Avg rating from 16 analysts suggest \"hold\"; their median PT is A$239, LSEG-complied data shows** Stock down 60.2% YTD, including the day's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N415089:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629098678","title":"ASX Midday Sector Update: Consumer Staples Stocks Rise, Cochlear Weighs on Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2629098678","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629098678?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:26","pubTimestamp":1776824761,"startTime":"0","endTime":"0","summary":"Consumer staples stock rose more than 1% to lead gainers in midday trading on Wednesday.Treasury Wine Estates  was advancing more than 16% after saying it will transition to a new regional operating model, effective Oct. 1, under which the company will have four regional divisions.On the flip side, health care stocks retreated over 5%, weighed down by a sharp decline for sector heavyweight Cochlear .The company's shares plunged more than 39% after it downgraded its fiscal year 2026 underlying net profit guidance, saying that trading conditions for its hearing implants in developed markets have been weaker than anticipated since January.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK7505","COH.AU","TWE.AU","BK7097","BK4581","BK7007","XBI","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629608320","title":"BRIEF-Cochlear Reduces Underlying Net Profit Guidance For Fy26 To A$290-330 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629608320","media":"Reuters","labels":["dataReport","event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629608320?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:32","pubTimestamp":1776821533,"startTime":"0","endTime":"0","summary":"BRIEF-Cochlear Reduces Underlying Net Profit Guidance For Fy26 To A$290-330 MillionApril 22 (Reuters) - Cochlear Ltd COH.AX:TRADING UPDATE AND REDUCTION TO FY26 EARNINGS GUIDANCESEES SECOND HALF SALES","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUE6N5WRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629255067","title":"BUZZ-Australia's Cochlear tanks on potential order cancellations, revised annual outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2629255067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629255067?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:26","pubTimestamp":1776821206,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cochlear tanks on potential order cancellations, revised annual outlook** Shares of Cochlear COH.AX fall as much as 39% to A$102.37, their lowest level since April 13, 2016** Stock marks its weakest intraday trading session ** The hearing implants maker now expects its underlying net profit for FY2026 to be between A$290 million and A$330 million  ** Company warned of risks arising from the Middle East conflict, including potential order cancellations** Expects nearly additional A$25 million aftertax hit to second-half earnings** Stock down 60.2% YTD, including the day's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N41501R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062007","title":"Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062007","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062007?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:14","pubTimestamp":1776820474,"startTime":"0","endTime":"0","summary":"UPDATE 2-Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impactSlashes FY26 earnings view sharply below consensusFlags soft trading conditions in developed marketsWarns of impact from strong Australian dollarShares end 40.7% lower in worst session everUpdates with details throughout","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N41500P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","LU2089284900.SGD","COH.AU","LU0289960550.SGD","BK4566","BK4548","BK4588","LU0158827781.USD","SG9999017495.SGD","LU0354030438.USD","LU0868494617.USD","LU1633808545.USD","LU0971096721.USD","LU1496350502.SGD","LU0345774391.USD","LU2506951875.HKD","LU0094547139.USD","LU1496350171.SGD","SG9999014880.SGD","LU2265009873.SGD","SG9999001077.SGD","BK4581","LU1989763005.USD","LU0154236417.USD","BK4597","LU1989772840.SGD","LU2023251221.USD","BK4112","LU0823417737.USD","LU1989772923.USD","SG9999014914.USD","LU0175139822.USD","BK4534","LU0158827948.USD","LU0950375773.USD","LU0354030511.USD","SGXZ31699556.SGD","SPGI","LU1804176565.USD","LU2111349929.HKD","IE00B19Z9505.USD","LU2764263203.CNY","LU1064131342.USD","LU2764263039.SGD","LU2506952097.USD","LU1988902786.USD","SG9999018857.SGD","LU2720916845.USD","LU1363072403.SGD","LU1989773731.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629506207","title":"Cochlear Says Trading Conditions for Implants Weaker Than Expected Since January; Shares Hit 10-Year Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2629506207","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629506207?lang=en_us&edition=fundamental","pubTime":"2026-04-22 09:09","pubTimestamp":1776820165,"startTime":"0","endTime":"0","summary":"Cochlear  said trading conditions for cochlear implants in developed markets have been weaker than anticipated since January, with uncertainty regarding fourth quarter sales from the Middle East due to ongoing conflict, according to a Wednesday filing with the Australian bourse.As a result, the company is downgrading its fiscal 2026 underlying net profit guidance to AU$290 million to AU$330 million, the filing said.The company had previously disclosed that it expected to be at the lower end of its underlying net profit guidance range of between AU$435 million and AU$460 million, per the filing.Shares fell 38% in morning trade Wednesday and earlier reached their lowest since March 2016.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629064183","title":"Cochlear cuts fiscal 2026 earnings outlook on Middle East‑led demand uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2629064183","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629064183?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:23","pubTimestamp":1776817392,"startTime":"0","endTime":"0","summary":"Cochlear cuts fiscal 2026 earnings outlook on Middle Eastled demand uncertaintyApril 22  - Australia's Cochlear COH.AX lowered on Wednesday its earnings outlook for fiscal year 2026, citing uncertainty and weaker demand linked to the Middle East conflict, sending shares of the hearing implant manufacturer 38.6% lower.The company now expects its underlying net profit for fiscal 2026 to be in the range of A$290 million to A$330 million , a sharp drop from its previous forecast of A$435 million - A$460 million.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N41500E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629061418","title":"Shares of Cochlear  Falls 38.6% to a$103.07, Lowest Level Since April 14, 2016","url":"https://stock-news.laohu8.com/highlight/detail?id=2629061418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629061418?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:04","pubTimestamp":1776816284,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4140TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","COH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102102824","title":"Stock Track | Cochlear Ltd Plummets 33.74% Intraday on Earnings Guidance Cut and Middle East Sales Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1102102824","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102102824?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:04","pubTimestamp":1776816284,"startTime":"0","endTime":"0","summary":"Cochlear Ltd's stock plummeted 33.74% during intraday trading on Wednesday.The sharp decline followed the company's trading update which included a reduction of its FY26 underlying net profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["COH.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629826066","title":"Cochlear Ltd - Sees Second Half Sales Growth of 2-6% in Constant Currency","url":"https://stock-news.laohu8.com/highlight/detail?id=2629826066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629826066?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:20","pubTimestamp":1776810010,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUE6N5WRN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COH.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":106,"code":"91000000","status":"200"}]}}